The diagnosis is also possible based on positive physio-pathologic markers of AD such as an abnormal level of amyloid beta and/or tau in the cerebrospinal fluid (CSF), or an abnormal load of amyloid beta and/or tau in the brain as revealed by PET. This evidence concerns the gene MAPT and Alzheimer disease.